According to World Health Organisation (WHO), in 2016, more than 1.9 billion adults, were overweight; of these over 650 million were obese. This means that about one-third of the overall global population is overweight and is fuelling by urbanization, poor diets, and lack of physical activity. The prevalence of obesity, and especially of morbid obesity, is increasing worldwide and is becoming a significant health hazard. Obesity is a known risk factor to develop diabetes, heart disease and high blood pressure. Many organizations and governments are conducting obesity awareness programs to increase the awareness regarding various treatment options and other option such as proper diet, exercise, and bariatric surgery available for obesity.

Rising awareness about surgery in obese population, lifestyle changes, increasing prevalence of obesity associated chronic diseases, growing awareness about obesity related complexities, lack of physical activity due to a sedentary lifestyle, changing modes of transportation, excessive consumption of fatty food, increasing prevalence of obesity leading to high demand for obesity surgeries, are factors fuelling demand for obesity surgical devices. High cost of obesity surgery is expected to hinder growth of the global obesity surgery devices market.

Get Sample Copy Of This Report: 

North America market is expected to account for major share in the global market in terms of revenue, owing to high expenditure on healthcare and increasing prevalence of obesity in the region. According to the bariatric surgery source in US almost 1 in every 3 people are obese. In 2017, obesity rates had reached with over 25 % of the population being obese in US and followed by over 15 % in Europe. Asia Pacific is the emerging market for obesity surgery devices, owing to rising prevalence of obesity, and booming medical tourism in the region. In 2017, prevalence of obesity in India was up to nearly 50% in women and nearly 30 % in men.

Prominent market players in global obesity surgery devices market include Johnson & Johnson, Mediflex Surgical Product, TransEnterix, Inc., Aspire Bariatrics, Inc., Apollo Endosurgery, Inc., Cousin Biotech, ReShape Lifesciences Inc., Allergan, Inc., Medtronic, Inc., and USGI Medical Inc.

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: